Waters Co. (NYSE:WAT) Shares Sold by Stiles Financial Services Inc

Stiles Financial Services Inc lowered its position in shares of Waters Co. (NYSE:WAT) by 12.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 763 shares of the medical instruments supplier’s stock after selling 105 shares during the quarter. Stiles Financial Services Inc’s holdings in Waters were worth $283,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in WAT. Advisory Alpha LLC lifted its position in shares of Waters by 2.6% in the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier’s stock valued at $395,000 after acquiring an additional 27 shares in the last quarter. Summit Trail Advisors LLC grew its stake in Waters by 2.4% during the 3rd quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock valued at $431,000 after acquiring an additional 28 shares in the last quarter. Empowered Funds LLC raised its holdings in Waters by 3.0% in the 4th quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier’s stock valued at $358,000 after acquiring an additional 28 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. boosted its holdings in shares of Waters by 0.3% during the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier’s stock worth $3,565,000 after purchasing an additional 30 shares during the last quarter. Finally, OneDigital Investment Advisors LLC boosted its holdings in shares of Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after purchasing an additional 31 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Down 0.5 %

NYSE:WAT opened at $408.96 on Monday. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The stock’s fifty day moving average is $389.56 and its two-hundred day moving average is $362.42. The stock has a market capitalization of $24.28 billion, a price-to-earnings ratio of 39.02, a price-to-earnings-growth ratio of 7.37 and a beta of 1.01. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14.

Analyst Ratings Changes

WAT has been the topic of a number of recent research reports. Scotiabank assumed coverage on Waters in a research note on Monday, December 23rd. They set a “sector perform” rating and a $430.00 price objective on the stock. Bank of America boosted their price target on shares of Waters from $400.00 to $430.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Wells Fargo & Company raised their price objective on shares of Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Stifel Nicolaus boosted their target price on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target for the company in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $384.71.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.